These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 7559432)
1. Covalent modification of human P-glycoprotein mutants containing a single cysteine in either nucleotide-binding fold abolishes drug-stimulated ATPase activity. Loo TW; Clarke DM J Biol Chem; 1995 Sep; 270(39):22957-61. PubMed ID: 7559432 [TBL] [Abstract][Full Text] [Related]
2. Drug-stimulated ATPase activity of human P-glycoprotein is blocked by disulfide cross-linking between the nucleotide-binding sites. Loo TW; Clarke DM J Biol Chem; 2000 Jun; 275(26):19435-8. PubMed ID: 10806188 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of oxidative cross-linking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 in predicted TM12 of human P-glycoprotein by drug substrates. Loo TW; Clarke DM J Biol Chem; 1996 Nov; 271(44):27482-7. PubMed ID: 8910331 [TBL] [Abstract][Full Text] [Related]
4. Rapid purification of human P-glycoprotein mutants expressed transiently in HEK 293 cells by nickel-chelate chromatography and characterization of their drug-stimulated ATPase activities. Loo TW; Clarke DM J Biol Chem; 1995 Sep; 270(37):21449-52. PubMed ID: 7665554 [TBL] [Abstract][Full Text] [Related]
5. Identification of residues in the drug-binding domain of human P-glycoprotein. Analysis of transmembrane segment 11 by cysteine-scanning mutagenesis and inhibition by dibromobimane. Loo TW; Clarke DM J Biol Chem; 1999 Dec; 274(50):35388-92. PubMed ID: 10585407 [TBL] [Abstract][Full Text] [Related]
6. Permanent activation of the human P-glycoprotein by covalent modification of a residue in the drug-binding site. Loo TW; Bartlett MC; Clarke DM J Biol Chem; 2003 Jun; 278(23):20449-52. PubMed ID: 12711602 [TBL] [Abstract][Full Text] [Related]
7. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains. Liu R; Sharom FJ Biochemistry; 1996 Sep; 35(36):11865-73. PubMed ID: 8794769 [TBL] [Abstract][Full Text] [Related]
8. Cysteines 431 and 1074 are responsible for inhibitory disulfide cross-linking between the two nucleotide-binding sites in human P-glycoprotein. Urbatsch IL; Gimi K; Wilke-Mounts S; Lerner-Marmarosh N; Rousseau ME; Gros P; Senior AE J Biol Chem; 2001 Jul; 276(29):26980-7. PubMed ID: 11356825 [TBL] [Abstract][Full Text] [Related]
10. Identification of residues within the drug-binding domain of the human multidrug resistance P-glycoprotein by cysteine-scanning mutagenesis and reaction with dibromobimane. Loo TW; Clarke DM J Biol Chem; 2000 Dec; 275(50):39272-8. PubMed ID: 11013259 [TBL] [Abstract][Full Text] [Related]
11. The "LSGGQ" motif in each nucleotide-binding domain of human P-glycoprotein is adjacent to the opposing walker A sequence. Loo TW; Bartlett MC; Clarke DM J Biol Chem; 2002 Nov; 277(44):41303-6. PubMed ID: 12226074 [TBL] [Abstract][Full Text] [Related]
12. Methanethiosulfonate derivatives of rhodamine and verapamil activate human P-glycoprotein at different sites. Loo TW; Bartlett MC; Clarke DM J Biol Chem; 2003 Dec; 278(50):50136-41. PubMed ID: 14522974 [TBL] [Abstract][Full Text] [Related]
13. Drug-stimulated nucleotide trapping in the human multidrug transporter MDR1. Cooperation of the nucleotide binding domains. Szabó K; Welker E; Bakos ; Müller M; Roninson I; Váradi A; Sarkadi B J Biol Chem; 1998 Apr; 273(17):10132-8. PubMed ID: 9553060 [TBL] [Abstract][Full Text] [Related]
14. Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein. Müller M; Bakos E; Welker E; Váradi A; Germann UA; Gottesman MM; Morse BS; Roninson IB; Sarkadi B J Biol Chem; 1996 Jan; 271(4):1877-83. PubMed ID: 8567633 [TBL] [Abstract][Full Text] [Related]
15. Disulfide cross-linking analysis shows that transmembrane segments 5 and 8 of human P-glycoprotein are close together on the cytoplasmic side of the membrane. Loo TW; Bartlett MC; Clarke DM J Biol Chem; 2004 Feb; 279(9):7692-7. PubMed ID: 14670948 [TBL] [Abstract][Full Text] [Related]
16. Covalent modification of cysteine 193 impairs ATPase function of nucleotide-binding domain of a Candida drug efflux pump. Jha S; Karnani N; Lynn AM; Prasad R Biochem Biophys Res Commun; 2003 Oct; 310(3):869-75. PubMed ID: 14550284 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region. Bakos E; Klein I; Welker E; Szabó K; Müller M; Sarkadi B; Váradi A Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):777-83. PubMed ID: 9169612 [TBL] [Abstract][Full Text] [Related]
18. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model. Garrigos M; Mir LM; Orlowski S Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038 [TBL] [Abstract][Full Text] [Related]
19. Identification of residues in the drug-binding site of human P-glycoprotein using a thiol-reactive substrate. Loo TW; Clarke DM J Biol Chem; 1997 Dec; 272(51):31945-8. PubMed ID: 9405384 [TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of the N-terminal nucleotide binding domain of an ABC drug transporter of Candida albicans: uncommon cysteine 193 of Walker A is critical for ATP hydrolysis. Jha S; Karnani N; Dhar SK; Mukhopadhayay K; Shukla S; Saini P; Mukhopadhayay G; Prasad R Biochemistry; 2003 Sep; 42(36):10822-32. PubMed ID: 12962507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]